PODD Oct 2024 230.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:03AM EDT. Market open.
| Previous close | 8.43 |
| Open | 8.65 |
| Bid | 8.90 |
| Ask | 10.30 |
| Strike | 230.00 |
| Expiry date | 2024-10-18 |
| Day's range | 8.43 - 8.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 28 |
ZacksIs Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?
The robust performance of Insulet's (PODD) Omnipod 5 raises investors' optimism. However, concerns remain over the macroeconomic impacts and the company's overdependence on a single platform.
GuruFocus.comInsider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)
Director Timothy Scannell of Insulet Corp (NASDAQ:PODD) sold 7,000 shares of the company on June 10, 2024, according to a recent SEC Filing.
Business WireInsulet to Present at the Jefferies Global Healthcare Conference
ACTON, Mass., May 28, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).
© 2024 Yahoo. All rights reserved.